Buscar
Mostrando ítems 1-10 de 10
Bioequivalence Study of Two Formulations Containing Rosuvastatin 40 Mg Tablets in Healthy Colombians
(Journal of J Bioequivalence & Bioavailability, 2015)
This is a pharmacokinetic study of two formulations containing Rosuvastatin 40 mg, with the aim to compare
the Bioavailability between the Test product (Rosuvastatin made by Laboratorios Tecnoquímicas S.A., Colombia)
and ...
Fed and Fasting Bioequivalence Study for Two Formulations of Bosentan 125 Mg Tablets in Healthy Colombian People
(Journal of J Bioequivalence & Bioavailability, 2015)
This is a pharmacokinetic study of two formulations containing Bosentan 125 mg, in order to compare the
bioavailability between the Test product (Bosentan produced by Tecnoquímicas S.A. laboratory, Colombia) and
the Reference ...
600 mg Oxcarbazepine Tablets Bioequivalence Study
(Journal of Bioequivalence & Bioavailability, 2017)
Bioequivalence studies are evidence of generic drugs quality, demonstrating that the rate and quantity of
effective substance absorbed from each of the studied formulations, showed no significant differences. The aim of
the ...
Bioequivalence Study of Two Formulations Containing Lurasidone 80 mg Tablets in Healthy Colombian Volunteers
(Journal of Bioequivalence & Bioavailability, 2016)
This is a pharmacokinetic study of two formulations containing Lurasidone 80 mg, with the aim to compare
the Bioavailability between the Test product (Lurasidone made by Laboratorios Lafrancol S.A, Colombia) and the
Reference ...
Bioequivalence Study of Imatinib Formulations that Contain 400 mg in Healthy Colombians
(Journal of Bioequivalence & Bioavailability, 2017)
A study with the aim to compare the bioavailability of two 400 mg imatinib formulations, test product Zeite® from
Laboratorio Synthesis S.A.S., Colombia, and reference product Glivec® from Novartis Pharma, and determine ...
Bioequivalence Study of Two Formulations Containing Irbesartan 300 Mg Tablets in Healthy Colombian Volunteers
(Journal of J Bioequivalence & Bioavailability, 2015)
This is a pharmacokinetic study of two formulations containing Irbesartan 300 mg. Its objective was to compare
the Bioavailability between the Test product (Irbesartan produced by Tecnoquímicas S.A., Colombia laboratory) ...
Bioequivalence Study of Two Formulations That Contain Isotretinoin 20 mg Capsules in Healthy Colombian Volunteers
(Journal of Bioequivalence & Bioavailability, 2016)
This is a pharmacokinetic test of two formulations that contain 20 mg of Isotretinoin, with the aim to compare the
bioavailability between the Test Product (Isoface® from Procaps Laboratory SA, Colombia) and the Reference ...
Bioequivalence Study of Two 50 mg Desvenlafaxine Extended Release Formulations: A Randomized, Single-Dose, Open-Label, Two Periods, Crossover Study
(Journal of J Bioequivalence & Bioavailability, 2014)
This is a pharmacokinetic study of two formulations containing Desvenlafaxine succinate 50 mg extended
release. Its objective was to compare the bioavailability between the Test product (Desvenlafaxine ER produced ...
Comparative Bioavailability of Two Extemporaneous Solid Formulations of Carbamazepine against the Innovator in Mexican Healthy Subjects
(OMICS International, 2014-03-04)